Home > Formulary : Adult > Recent Decisions > 2015 >
Decisions 3rd March 2015
New Drug Requests
Approved
Lidocaine 5% topical Patch (Versatis®) (TLS Red)
- Approved in the management of pain secondary to isolated rib fractures.
Methoxsalen (Uvadex®) (TLS Red)
- Approved for use in the Bristol Apheresis unit.
More information required
Infliximab Biosimilars (Inflectra® and Remsima®)
- Approved for inclusion onto the formulary.
Aclidinium bromide and Formoterol fumarate (Duaklir Genuair®)
-
Await SMC advice.
Shared Care Protocols/TLS Change in Status
Naltrexone (Opiates/alcohol)
- More work required to make them more concise.
Lanthanum SCP
- Updated SCP agreed.
Sevelamer (Renagel®) SCP
- Updated SCP agreed.
Other inclusions agreed to the formulary:
Ajmaline (TLS Red)
- Approved for inclusion onto the formulary for use in the diagnostic tests for Brugada syndrome. Previosuly approved through UHB MAG.
Meningitis B vaccine (TLS Blue)
- Approved for inclusion onto the formulary as the Department of Health recommend the vaccine for those without a functioning spleen.